🔗 Share this article Patients Coming Off Weight-Loss Jabs Gain Back Weight Far More Rapidly Than Those on Conventional Diets Obesity treatment involves ongoing approaches. A recent study suggests that individuals who discontinue new weight-loss injections like Wegovy and Mounjaro can put back on reduced body mass at a significantly accelerated pace than those who halt conventional diet and exercise programs. Research printed in a major medical journal demonstrates that while overweight individuals can lose about a fifth of their body weight while using the jabs, the mass returns at an average rate of nearly a kilo each month upon discontinuation. "Users using these treatments need to be aware of the potential of rapid weight regain when the treatment concludes," warns expert Dr. Susan Jebb. Such speed of recovery implies a return to starting weight in about one and a half years. Weighing Treatments The study, which examined dozens of trials involving thousands of participants, compared the results of GLP-1 agonists with older methods. The team note that people who lose weight through diet and exercise generally experience a more gradual weight regain—approximately 0.1 kg a month—once they finish. Explaining the Fast Regain Experts believe the way of the injections explains the heightened rebound. These medications mimic a body's own chemical called GLP-1, which moderates feelings of fullness. "Artificially providing the hormone concentrations several times higher than normal could lead to the body to generate a reduced amount of its endogenous GLP-1, and could reduce responsiveness to its effects," said Dr. Adam Collins, a dietetics expert. "Discontinuation of this medication leads to hunger is no longer kept in check, making overeating much more probable." A Chronic Condition? The NHS suggest the injections for individuals with obesity-related medical conditions, alongside prescribed lifestyle changes. A number of clinicians argue that, due to the likelihood of relapse, the therapy should be considered ongoing. This opinion is supported by drug manufacturers, who say that the results "emphasize the long-term character of obesity," akin to managing conditions like diabetes. Patient Testimonies People who have come off the medication report a powerful return of appetite. "I experienced a switch flipping and you're instantly starving," described a patient. The struggle is compounded if users have not developed permanent lifestyle or habit changes during treatment. Significant Use Recent estimates indicate that a significant number of people in the UK have used weight-loss jabs in the past year, with interest continuing to grow. Adoption is higher among females compared to men. The middle-aged demographic shows the greatest level of interest. A large proportion obtain the drugs through private healthcare rather than public health services. In conclusion, researchers stress that while GLP-1 drugs are potent agents for weight loss, they are not a permanent solution and long-term success hinges on integrated lifestyle management.
Obesity treatment involves ongoing approaches. A recent study suggests that individuals who discontinue new weight-loss injections like Wegovy and Mounjaro can put back on reduced body mass at a significantly accelerated pace than those who halt conventional diet and exercise programs. Research printed in a major medical journal demonstrates that while overweight individuals can lose about a fifth of their body weight while using the jabs, the mass returns at an average rate of nearly a kilo each month upon discontinuation. "Users using these treatments need to be aware of the potential of rapid weight regain when the treatment concludes," warns expert Dr. Susan Jebb. Such speed of recovery implies a return to starting weight in about one and a half years. Weighing Treatments The study, which examined dozens of trials involving thousands of participants, compared the results of GLP-1 agonists with older methods. The team note that people who lose weight through diet and exercise generally experience a more gradual weight regain—approximately 0.1 kg a month—once they finish. Explaining the Fast Regain Experts believe the way of the injections explains the heightened rebound. These medications mimic a body's own chemical called GLP-1, which moderates feelings of fullness. "Artificially providing the hormone concentrations several times higher than normal could lead to the body to generate a reduced amount of its endogenous GLP-1, and could reduce responsiveness to its effects," said Dr. Adam Collins, a dietetics expert. "Discontinuation of this medication leads to hunger is no longer kept in check, making overeating much more probable." A Chronic Condition? The NHS suggest the injections for individuals with obesity-related medical conditions, alongside prescribed lifestyle changes. A number of clinicians argue that, due to the likelihood of relapse, the therapy should be considered ongoing. This opinion is supported by drug manufacturers, who say that the results "emphasize the long-term character of obesity," akin to managing conditions like diabetes. Patient Testimonies People who have come off the medication report a powerful return of appetite. "I experienced a switch flipping and you're instantly starving," described a patient. The struggle is compounded if users have not developed permanent lifestyle or habit changes during treatment. Significant Use Recent estimates indicate that a significant number of people in the UK have used weight-loss jabs in the past year, with interest continuing to grow. Adoption is higher among females compared to men. The middle-aged demographic shows the greatest level of interest. A large proportion obtain the drugs through private healthcare rather than public health services. In conclusion, researchers stress that while GLP-1 drugs are potent agents for weight loss, they are not a permanent solution and long-term success hinges on integrated lifestyle management.